Dose-Independent Pharmacokinetics of a New Neuroprotective Agent for Ischemia-Reperfusion Damage, KR-31543, after Intravenous and Oral Administration to Rats: Hepatic and Intestinal First-Pass Effects
- 1 January 2003
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 92 (1) , 190-201
- https://doi.org/10.1002/jps.10289
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to ratsLife Sciences, 2002
- Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA‐8159, using an equilibrium dialysis techniqueBiopharmaceutics & Drug Disposition, 2000
- Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?Trends in Neurosciences, 1999
- Liver and Gastrointestinal First-pass Effects of Azosemide in RatsJournal of Pharmacy and Pharmacology, 1997
- Pharmacokinetics and pharmacodynamics of furosemide in protein-calorie malnutritionJournal of Pharmacokinetics and Biopharmaceutics, 1993
- Kinetics of Aluminum in Rats. Ill: Effect of Route of AdministrationJournal of Pharmaceutical Sciences, 1992
- New Calculation method of mean Total Body Clearance of Drugs and its Application to Dosage RegimensJournal of Pharmaceutical Sciences, 1980
- New Calculation Method for Mean Apparent Drug Volume of Distribution and Application to Rational Dosage RegimensJournal of Pharmaceutical Sciences, 1979
- Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level-time curveJournal of Pharmacokinetics and Biopharmaceutics, 1978
- Pharmacokinetics of diazepam following multiple-dose oral administration to healthy human subjectsJournal of Pharmacokinetics and Biopharmaceutics, 1977